Latest News & Features
Americas
On July 21 the US Court of Appeals for the Federal Circuit ruled in Amgen v Sandoz that biosimilar applicants can opt out of the ‘patent dance’. Courtenay Brinckerhoff of Foley & Lardner considers the decision’s implications for the biosimilars framework and highlights the questions that remain unanswered. 30 July 2015
Americas
Middle Eastern pharmaceutical company Hikma Pharmaceuticals has agreed to buy Roxane Laboratories from Boehringer Ingelheim for $2.65 billion. 30 July 2015
Big Pharma
Bayer has claimed victory after a US district court ruled that a generic version of one of its skin treatment drugs proposed by Glenmark Pharmaceuticals infringed its patent. 28 July 2015
Americas
Medical device manufacturer Medtronic has asked the US Supreme Court to vacate a lower court ruling that it indirectly infringed a patent covering a machine used during spinal surgery, citing the latest ruling in Commil USA v Cisco Systems. 28 July 2015
Asia
Pharmaceutical company Teva has bought Allergan Generics from drugs business Allergan in a $40.5 billion deal. 27 July 2015
Americas
Biotechnology company United Therapeutics has sued Watson Laboratories claiming it has infringed three of its patents covering one of its hypertension treatment drugs. 24 July 2015
Americas
Enzo Life Sciences has agreed to settle a patent infringement dispute with Siemens Healthcare Diagnostics, in what was one of 12 cases that Enzo had filed simultaneously. 24 July 2015
Americas
The US Court of Appeals for the Federal Circuit’s decision in Amgen v Sandoz is what the biosimilar industry would have been hoping for but clarity is lacking in several areas, lawyers have told LSIPR. 23 July 2015
Americas
Law firm Hughes Hubbard & Reed has expanded its intellectual property practice by hiring Patrice Jean as a partner. 23 July 2015
Americas
Biopharma parties thinking about challenging a patent via an inter partes review should be aware that there are significant differences between district court and IPR practice, as Tasha Francis and Dorothy Whelan of Fish & Richardson explain. 23 July 2015